TABLE 3.
Percentage of DBMSCs expressing surface ligands that bind to NK-activating and NK-inhibiting receptors.
DNAM-1 activating receptor ligands | NKG2D activating receptor ligands | CD94/NKG2 inhibiting receptor ligand | ||||||
---|---|---|---|---|---|---|---|---|
PVR (CD155) | Nectin-2 (CD112) | ULBP-1 | ULBP-2 | ULBP-3 | MICA | MICB | HLA-E | HLA-ABC |
22.00% ± 9.07% | 0.76% ± 0.38% | 2.067% ± 0.533% | 4.63% ± 2.19% | 1.93% ± 0.83% | 2.66% ± 2.18% | 0.96% ± 0.966% | 22.00% ± 9.07% | 97.00% ± 3.00% |